Close Menu

NEW YORK — Aiforia said on Monday that it has received a €2.1 million ($2.3 million) grant to continue development of its artificial intelligence-based digital pathology technologies for primary cancer diagnosis.

According to the Finnish company, the grant was awarded under the European Union's Horizon 2020 program and will be used to develop deep learning AI models that can help diagnose common cancer types including prostate and lung cancers.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Aug
19
Sponsored by
UgenTec

This webinar will present a case study from in vitro diagnostics developer SpeeDx on its experience building a complete sample-to-result workflow — encompassing instrumentation and data analysis software — for its qPCR-based ResistancePlus MG Mycoplasma genitalium assay.